| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tight Junctions | 28 | 2022 | 150 | 4.100 |
Why?
|
| Intestinal Mucosa | 24 | 2020 | 805 | 2.630 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 9 | 2022 | 229 | 2.030 |
Why?
|
| Epithelium | 8 | 2020 | 325 | 1.320 |
Why?
|
| Epithelial Cells | 13 | 2019 | 689 | 1.300 |
Why?
|
| Occludin | 16 | 2020 | 66 | 1.070 |
Why?
|
| Endocytosis | 8 | 2013 | 180 | 0.930 |
Why?
|
| Membrane Proteins | 16 | 2019 | 1225 | 0.910 |
Why?
|
| Myosin-Light-Chain Kinase | 11 | 2013 | 41 | 0.880 |
Why?
|
| Claudins | 8 | 2022 | 33 | 0.800 |
Why?
|
| Zonula Occludens-1 Protein | 12 | 2020 | 70 | 0.770 |
Why?
|
| KRIT1 Protein | 4 | 2022 | 62 | 0.760 |
Why?
|
| Cell Membrane Permeability | 5 | 2018 | 120 | 0.760 |
Why?
|
| Myosin Type II | 3 | 2018 | 50 | 0.690 |
Why?
|
| rho-Associated Kinases | 5 | 2018 | 160 | 0.670 |
Why?
|
| Signal Transduction | 13 | 2021 | 3393 | 0.640 |
Why?
|
| Apoptosis | 6 | 2021 | 1720 | 0.570 |
Why?
|
| Caco-2 Cells | 13 | 2019 | 123 | 0.500 |
Why?
|
| Actins | 7 | 2018 | 460 | 0.440 |
Why?
|
| Animals | 42 | 2022 | 27428 | 0.430 |
Why?
|
| Apoptosis Regulatory Proteins | 5 | 2020 | 198 | 0.420 |
Why?
|
| Tumor Necrosis Factor-alpha | 8 | 2020 | 699 | 0.420 |
Why?
|
| Phosphoproteins | 8 | 2012 | 261 | 0.390 |
Why?
|
| Colon | 5 | 2022 | 511 | 0.370 |
Why?
|
| Paneth Cells | 1 | 2020 | 10 | 0.360 |
Why?
|
| Mice | 26 | 2022 | 11792 | 0.360 |
Why?
|
| Permeability | 9 | 2015 | 138 | 0.360 |
Why?
|
| Myosin Light Chains | 5 | 2013 | 29 | 0.360 |
Why?
|
| Stem Cell Niche | 1 | 2020 | 22 | 0.350 |
Why?
|
| Colitis | 5 | 2019 | 245 | 0.350 |
Why?
|
| Arginine | 1 | 2020 | 138 | 0.350 |
Why?
|
| Adherens Junctions | 1 | 2008 | 34 | 0.310 |
Why?
|
| Gastric Mucosa | 1 | 2009 | 68 | 0.310 |
Why?
|
| Intestine, Small | 1 | 2020 | 299 | 0.310 |
Why?
|
| Claudin-2 | 3 | 2017 | 10 | 0.300 |
Why?
|
| Cadherins | 1 | 2008 | 163 | 0.300 |
Why?
|
| Intestines | 4 | 2020 | 416 | 0.300 |
Why?
|
| Stem Cells | 1 | 2020 | 375 | 0.300 |
Why?
|
| Organoids | 2 | 2022 | 63 | 0.290 |
Why?
|
| MicroRNAs | 2 | 2022 | 556 | 0.280 |
Why?
|
| Endothelium | 2 | 2020 | 58 | 0.280 |
Why?
|
| Caveolae | 2 | 2007 | 6 | 0.270 |
Why?
|
| Phosphorylation | 7 | 2018 | 1134 | 0.270 |
Why?
|
| Enterocolitis | 1 | 2006 | 13 | 0.270 |
Why?
|
| Mice, Inbred C57BL | 12 | 2020 | 3225 | 0.270 |
Why?
|
| Models, Biological | 6 | 2020 | 1767 | 0.260 |
Why?
|
| Humans | 38 | 2024 | 89630 | 0.250 |
Why?
|
| Disease Models, Animal | 9 | 2020 | 2377 | 0.240 |
Why?
|
| Povidone-Iodine | 1 | 2024 | 9 | 0.240 |
Why?
|
| Microvilli | 2 | 2018 | 43 | 0.240 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2024 | 24 | 0.230 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2005 | 565 | 0.220 |
Why?
|
| Mice, Transgenic | 10 | 2019 | 1577 | 0.220 |
Why?
|
| Actin Cytoskeleton | 5 | 2018 | 196 | 0.210 |
Why?
|
| Circulating MicroRNA | 1 | 2022 | 13 | 0.210 |
Why?
|
| Dogs | 5 | 2015 | 704 | 0.210 |
Why?
|
| Cell Membrane | 3 | 2018 | 675 | 0.200 |
Why?
|
| Mebendazole | 1 | 2021 | 6 | 0.190 |
Why?
|
| Antinematodal Agents | 1 | 2021 | 7 | 0.190 |
Why?
|
| Cell Line | 8 | 2015 | 2496 | 0.190 |
Why?
|
| Sodium-Potassium-Chloride Symporters | 2 | 2012 | 22 | 0.190 |
Why?
|
| Brain | 4 | 2020 | 2289 | 0.190 |
Why?
|
| Claudin-1 | 4 | 2011 | 17 | 0.190 |
Why?
|
| MAP Kinase Kinase Kinase 3 | 1 | 2020 | 13 | 0.180 |
Why?
|
| Atrioventricular Node | 1 | 2020 | 35 | 0.170 |
Why?
|
| Homeostasis | 2 | 2020 | 417 | 0.170 |
Why?
|
| Plasma Cells | 1 | 2020 | 84 | 0.170 |
Why?
|
| Hemangioma, Cavernous | 1 | 2020 | 69 | 0.170 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2020 | 262 | 0.170 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2020 | 85 | 0.170 |
Why?
|
| Autoantigens | 1 | 2020 | 129 | 0.170 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2019 | 25 | 0.160 |
Why?
|
| Caspase 3 | 1 | 2019 | 162 | 0.160 |
Why?
|
| Cisplatin | 1 | 2021 | 618 | 0.160 |
Why?
|
| Autoantibodies | 1 | 2020 | 268 | 0.160 |
Why?
|
| Mutant Proteins | 1 | 2019 | 96 | 0.160 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2019 | 85 | 0.160 |
Why?
|
| Calcium | 3 | 2019 | 1177 | 0.160 |
Why?
|
| Up-Regulation | 3 | 2017 | 728 | 0.150 |
Why?
|
| Ion Channels | 1 | 2020 | 246 | 0.150 |
Why?
|
| Mice, Knockout | 7 | 2019 | 2003 | 0.150 |
Why?
|
| Cholesterol | 2 | 2014 | 360 | 0.150 |
Why?
|
| Actomyosin | 1 | 2018 | 46 | 0.150 |
Why?
|
| T-Box Domain Proteins | 1 | 2019 | 124 | 0.150 |
Why?
|
| Gastrointestinal Tract | 1 | 2019 | 191 | 0.150 |
Why?
|
| Heart Rate | 1 | 2020 | 498 | 0.150 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2021 | 618 | 0.150 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2017 | 24 | 0.140 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2020 | 196 | 0.140 |
Why?
|
| Interleukins | 1 | 2017 | 129 | 0.140 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2020 | 511 | 0.140 |
Why?
|
| Microtubules | 2 | 2014 | 123 | 0.140 |
Why?
|
| Cytoskeleton | 2 | 2008 | 195 | 0.130 |
Why?
|
| Diarrhea | 1 | 2017 | 182 | 0.130 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2019 | 666 | 0.130 |
Why?
|
| Inflammatory Bowel Diseases | 5 | 2013 | 581 | 0.130 |
Why?
|
| X-Ray Microtomography | 1 | 2016 | 91 | 0.130 |
Why?
|
| Enterovirus B, Human | 1 | 2015 | 10 | 0.120 |
Why?
|
| CD55 Antigens | 1 | 2015 | 21 | 0.120 |
Why?
|
| Enterovirus Infections | 1 | 2015 | 41 | 0.120 |
Why?
|
| Protein Transport | 4 | 2014 | 421 | 0.120 |
Why?
|
| Disease Progression | 1 | 2019 | 1492 | 0.120 |
Why?
|
| Biological Transport | 1 | 2015 | 401 | 0.120 |
Why?
|
| Ovarian Neoplasms | 1 | 2021 | 766 | 0.120 |
Why?
|
| Transcriptome | 1 | 2019 | 635 | 0.120 |
Why?
|
| Atrial Fibrillation | 1 | 2019 | 357 | 0.120 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 1 | 2014 | 3 | 0.120 |
Why?
|
| Disease Susceptibility | 1 | 2015 | 201 | 0.110 |
Why?
|
| Liver Diseases | 1 | 2015 | 242 | 0.110 |
Why?
|
| Dextran Sulfate | 3 | 2019 | 68 | 0.110 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2013 | 20 | 0.110 |
Why?
|
| Microscopy, Fluorescence | 4 | 2010 | 432 | 0.110 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2013 | 43 | 0.110 |
Why?
|
| Ethanol | 1 | 2015 | 252 | 0.110 |
Why?
|
| Caveolin 1 | 2 | 2010 | 21 | 0.110 |
Why?
|
| Capsaicin | 1 | 2012 | 45 | 0.110 |
Why?
|
| TRPV Cation Channels | 1 | 2012 | 16 | 0.110 |
Why?
|
| Casein Kinase II | 1 | 2012 | 11 | 0.100 |
Why?
|
| Chlorides | 1 | 2012 | 103 | 0.100 |
Why?
|
| Lymphatic Vessels | 1 | 2013 | 69 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 3 | 2022 | 282 | 0.100 |
Why?
|
| Endothelial Cells | 3 | 2020 | 461 | 0.100 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 3 | 2012 | 90 | 0.100 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2012 | 105 | 0.100 |
Why?
|
| Lung | 2 | 2020 | 1266 | 0.100 |
Why?
|
| Wound Healing | 2 | 2021 | 360 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2022 | 887 | 0.090 |
Why?
|
| Protein Kinase C | 2 | 2008 | 268 | 0.090 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2011 | 86 | 0.090 |
Why?
|
| Immunity, Innate | 2 | 2017 | 430 | 0.090 |
Why?
|
| Cell Proliferation | 2 | 2021 | 1654 | 0.090 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2012 | 275 | 0.090 |
Why?
|
| Dynamin II | 2 | 2011 | 15 | 0.090 |
Why?
|
| Interferon-gamma | 3 | 2008 | 451 | 0.090 |
Why?
|
| Interleukin-13 | 1 | 2010 | 38 | 0.090 |
Why?
|
| Myosin Heavy Chains | 2 | 2020 | 91 | 0.090 |
Why?
|
| Clathrin | 1 | 2009 | 29 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 2415 | 0.090 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2009 | 137 | 0.080 |
Why?
|
| Protein Binding | 5 | 2013 | 1490 | 0.080 |
Why?
|
| Wnt Signaling Pathway | 1 | 2020 | 98 | 0.080 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2008 | 12 | 0.080 |
Why?
|
| Microscopy, Electron | 2 | 2022 | 511 | 0.080 |
Why?
|
| Immunity, Mucosal | 1 | 2009 | 70 | 0.080 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2008 | 13 | 0.080 |
Why?
|
| Immunohistochemistry | 4 | 2015 | 1801 | 0.080 |
Why?
|
| Sodium-Hydrogen Exchangers | 1 | 2008 | 77 | 0.080 |
Why?
|
| Diffusion | 1 | 2008 | 93 | 0.080 |
Why?
|
| Thiazolidines | 2 | 2005 | 17 | 0.080 |
Why?
|
| Organ Specificity | 1 | 2009 | 273 | 0.080 |
Why?
|
| DNA Primers | 2 | 2022 | 544 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2018 | 387 | 0.080 |
Why?
|
| Multiprotein Complexes | 1 | 2008 | 96 | 0.070 |
Why?
|
| Cell Polarity | 1 | 2008 | 116 | 0.070 |
Why?
|
| Tumor Necrosis Factor Ligand Superfamily Member 14 | 1 | 2007 | 14 | 0.070 |
Why?
|
| Acute Disease | 2 | 2020 | 842 | 0.070 |
Why?
|
| Thiazoles | 2 | 2005 | 128 | 0.070 |
Why?
|
| Time Factors | 4 | 2024 | 5344 | 0.070 |
Why?
|
| Bacterial Infections | 1 | 2009 | 184 | 0.070 |
Why?
|
| Serotonin | 1 | 2008 | 221 | 0.070 |
Why?
|
| Myocytes, Cardiac | 2 | 2020 | 314 | 0.070 |
Why?
|
| Claudin-4 | 2 | 2020 | 8 | 0.070 |
Why?
|
| Enzyme Induction | 1 | 2006 | 88 | 0.070 |
Why?
|
| Cells, Cultured | 3 | 2019 | 2884 | 0.070 |
Why?
|
| Cytokines | 4 | 2017 | 804 | 0.070 |
Why?
|
| Chronic Disease | 2 | 2020 | 950 | 0.070 |
Why?
|
| RNA, Small Interfering | 3 | 2014 | 557 | 0.060 |
Why?
|
| Intestinal Absorption | 1 | 2006 | 124 | 0.060 |
Why?
|
| T-Lymphocytes | 2 | 2018 | 1226 | 0.060 |
Why?
|
| Clathrin-Coated Vesicles | 1 | 2005 | 7 | 0.060 |
Why?
|
| Porins | 1 | 2005 | 21 | 0.060 |
Why?
|
| Adhesins, Bacterial | 1 | 2005 | 36 | 0.060 |
Why?
|
| Lectins | 1 | 2005 | 84 | 0.060 |
Why?
|
| Cell Line, Tumor | 3 | 2021 | 2565 | 0.060 |
Why?
|
| Ion Transport | 2 | 2018 | 81 | 0.060 |
Why?
|
| Genes, Reporter | 1 | 2005 | 275 | 0.060 |
Why?
|
| Drug Storage | 1 | 2024 | 4 | 0.060 |
Why?
|
| Computational Biology | 1 | 2008 | 550 | 0.060 |
Why?
|
| Ophthalmic Solutions | 1 | 2024 | 17 | 0.060 |
Why?
|
| Eye Infections, Bacterial | 1 | 2024 | 16 | 0.060 |
Why?
|
| Drosophila | 1 | 2008 | 522 | 0.060 |
Why?
|
| Triglycerides | 2 | 2015 | 232 | 0.060 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2024 | 150 | 0.060 |
Why?
|
| Cell Movement | 2 | 2021 | 785 | 0.060 |
Why?
|
| Drosophila Proteins | 1 | 2008 | 510 | 0.060 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2005 | 202 | 0.060 |
Why?
|
| Computer Simulation | 1 | 2008 | 1100 | 0.060 |
Why?
|
| Freeze Fracturing | 1 | 2022 | 12 | 0.050 |
Why?
|
| Tissue Distribution | 3 | 2010 | 293 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2022 | 2763 | 0.050 |
Why?
|
| Phenotype | 2 | 2020 | 2447 | 0.050 |
Why?
|
| Receptor Aggregation | 1 | 2002 | 3 | 0.050 |
Why?
|
| beta-Cyclodextrins | 1 | 2002 | 9 | 0.050 |
Why?
|
| Ligands | 2 | 2019 | 445 | 0.050 |
Why?
|
| Binding Sites | 2 | 2018 | 1118 | 0.050 |
Why?
|
| Gene Knockdown Techniques | 2 | 2013 | 247 | 0.050 |
Why?
|
| fas Receptor | 1 | 2002 | 77 | 0.050 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2021 | 37 | 0.050 |
Why?
|
| Drug Discovery | 1 | 2022 | 107 | 0.050 |
Why?
|
| Blotting, Western | 2 | 2014 | 795 | 0.050 |
Why?
|
| Solute Carrier Family 12, Member 2 | 2 | 2012 | 16 | 0.050 |
Why?
|
| Male | 6 | 2020 | 42561 | 0.050 |
Why?
|
| Drug Repositioning | 1 | 2021 | 23 | 0.050 |
Why?
|
| Female | 6 | 2021 | 46361 | 0.050 |
Why?
|
| Cyclic N-Oxides | 1 | 2020 | 33 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 2 | 2012 | 309 | 0.050 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 2020 | 36 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2022 | 371 | 0.040 |
Why?
|
| Cholecalciferol | 1 | 2020 | 35 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 2 | 2013 | 740 | 0.040 |
Why?
|
| Vimentin | 1 | 2020 | 46 | 0.040 |
Why?
|
| Bacteria | 1 | 2024 | 481 | 0.040 |
Why?
|
| Spin Labels | 1 | 2020 | 106 | 0.040 |
Why?
|
| Tight Junction Proteins | 1 | 2020 | 14 | 0.040 |
Why?
|
| Tubulin | 1 | 2020 | 59 | 0.040 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2020 | 18 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2002 | 313 | 0.040 |
Why?
|
| Liver | 2 | 2015 | 1210 | 0.040 |
Why?
|
| Carrier Proteins | 2 | 2019 | 681 | 0.040 |
Why?
|
| Trinitrobenzenesulfonic Acid | 1 | 2019 | 16 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 472 | 0.040 |
Why?
|
| Connexin 43 | 1 | 2020 | 94 | 0.040 |
Why?
|
| Metagenomics | 1 | 2020 | 91 | 0.040 |
Why?
|
| Astrocytes | 1 | 2020 | 141 | 0.040 |
Why?
|
| Respiratory Mucosa | 1 | 2020 | 88 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2021 | 818 | 0.040 |
Why?
|
| DNA, Bacterial | 1 | 2020 | 244 | 0.040 |
Why?
|
| Cations, Divalent | 1 | 2019 | 39 | 0.040 |
Why?
|
| Middle Aged | 4 | 2020 | 26069 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2020 | 250 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2022 | 463 | 0.040 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2019 | 91 | 0.040 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2020 | 125 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2020 | 344 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2022 | 486 | 0.040 |
Why?
|
| Zonula Occludens-2 Protein | 1 | 2018 | 11 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2020 | 294 | 0.040 |
Why?
|
| Biological Transport, Active | 1 | 2018 | 102 | 0.040 |
Why?
|
| Connexins | 1 | 2020 | 201 | 0.040 |
Why?
|
| Feces | 1 | 2020 | 331 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2020 | 284 | 0.040 |
Why?
|
| Dynamins | 1 | 2018 | 50 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2020 | 641 | 0.040 |
Why?
|
| Dexamethasone | 1 | 2019 | 344 | 0.040 |
Why?
|
| Enzyme Activation | 2 | 2010 | 698 | 0.040 |
Why?
|
| Citrobacter rodentium | 1 | 2017 | 14 | 0.040 |
Why?
|
| Iron | 1 | 2018 | 168 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2020 | 873 | 0.040 |
Why?
|
| Protein Multimerization | 1 | 2018 | 177 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 309 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2018 | 212 | 0.030 |
Why?
|
| Caspases | 2 | 2011 | 155 | 0.030 |
Why?
|
| Histological Techniques | 1 | 2016 | 36 | 0.030 |
Why?
|
| Cerebellum | 1 | 2018 | 249 | 0.030 |
Why?
|
| Aged | 3 | 2020 | 19237 | 0.030 |
Why?
|
| Iodine | 1 | 2016 | 43 | 0.030 |
Why?
|
| Inulin | 1 | 2015 | 17 | 0.030 |
Why?
|
| Sodium | 1 | 2017 | 331 | 0.030 |
Why?
|
| Recombinant Proteins | 2 | 2010 | 1012 | 0.030 |
Why?
|
| Water | 1 | 2017 | 284 | 0.030 |
Why?
|
| Organ Size | 1 | 2016 | 370 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2019 | 1863 | 0.030 |
Why?
|
| Dynactin Complex | 1 | 2014 | 2 | 0.030 |
Why?
|
| Benzyl Compounds | 1 | 2014 | 7 | 0.030 |
Why?
|
| Patch-Clamp Techniques | 1 | 2015 | 396 | 0.030 |
Why?
|
| Nocodazole | 1 | 2014 | 18 | 0.030 |
Why?
|
| Observer Variation | 1 | 2016 | 612 | 0.030 |
Why?
|
| Dyneins | 1 | 2014 | 14 | 0.030 |
Why?
|
| Madin Darby Canine Kidney Cells | 1 | 2014 | 19 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2015 | 273 | 0.030 |
Why?
|
| Adult | 3 | 2020 | 26699 | 0.030 |
Why?
|
| Tubulin Modulators | 1 | 2014 | 24 | 0.030 |
Why?
|
| Lymphocyte Activation | 2 | 2009 | 753 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 323 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2020 | 784 | 0.030 |
Why?
|
| Cholesterol, VLDL | 1 | 2014 | 14 | 0.030 |
Why?
|
| Adenine | 1 | 2014 | 88 | 0.030 |
Why?
|
| Jejunum | 1 | 2014 | 80 | 0.030 |
Why?
|
| Golgi Apparatus | 1 | 2014 | 116 | 0.030 |
Why?
|
| Biomarkers | 1 | 2020 | 1770 | 0.030 |
Why?
|
| B-Lymphocytes | 1 | 2018 | 740 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2014 | 184 | 0.030 |
Why?
|
| RNA Interference | 1 | 2014 | 376 | 0.030 |
Why?
|
| Diterpenes | 1 | 2012 | 21 | 0.030 |
Why?
|
| Colforsin | 1 | 2012 | 74 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2013 | 205 | 0.030 |
Why?
|
| Biotinylation | 1 | 2012 | 42 | 0.030 |
Why?
|
| Acrylamides | 1 | 2012 | 34 | 0.030 |
Why?
|
| Adoptive Transfer | 1 | 2013 | 169 | 0.030 |
Why?
|
| Electric Conductivity | 1 | 2012 | 144 | 0.030 |
Why?
|
| Crohn Disease | 1 | 2019 | 762 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2014 | 226 | 0.030 |
Why?
|
| Colitis, Ulcerative | 1 | 2019 | 740 | 0.030 |
Why?
|
| Weight Loss | 1 | 2013 | 229 | 0.020 |
Why?
|
| Contrast Media | 1 | 2016 | 1092 | 0.020 |
Why?
|
| Dopamine | 1 | 2012 | 276 | 0.020 |
Why?
|
| Luminescent Proteins | 1 | 2011 | 144 | 0.020 |
Why?
|
| MARVEL Domain Containing 2 Protein | 1 | 2010 | 2 | 0.020 |
Why?
|
| Electrophysiology | 1 | 2011 | 403 | 0.020 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2010 | 29 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2010 | 94 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2010 | 81 | 0.020 |
Why?
|
| Plasmids | 1 | 2010 | 291 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2010 | 419 | 0.020 |
Why?
|
| Egtazic Acid | 1 | 2008 | 33 | 0.020 |
Why?
|
| Protein Kinase C-delta | 1 | 2008 | 26 | 0.020 |
Why?
|
| Protein Kinase C-alpha | 1 | 2008 | 27 | 0.020 |
Why?
|
| Mucous Membrane | 1 | 2008 | 83 | 0.020 |
Why?
|
| Carbazoles | 1 | 2008 | 33 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 1944 | 0.020 |
Why?
|
| Major Histocompatibility Complex | 1 | 2008 | 84 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2008 | 136 | 0.020 |
Why?
|
| Young Adult | 1 | 2020 | 6350 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2008 | 278 | 0.020 |
Why?
|
| Adolescent | 1 | 2020 | 9289 | 0.020 |
Why?
|
| Lymphotoxin beta Receptor | 1 | 2007 | 29 | 0.020 |
Why?
|
| Cardiac Myosins | 1 | 2007 | 19 | 0.020 |
Why?
|
| Glucose | 1 | 2009 | 630 | 0.020 |
Why?
|
| Mutation | 1 | 2018 | 4162 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2010 | 2063 | 0.020 |
Why?
|
| Base Sequence | 1 | 2010 | 2329 | 0.020 |
Why?
|
| Pyocyanine | 1 | 2005 | 12 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2008 | 446 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2010 | 3027 | 0.020 |
Why?
|
| Computer Systems | 1 | 2005 | 79 | 0.020 |
Why?
|
| Virulence | 1 | 2005 | 281 | 0.010 |
Why?
|
| Kidney | 1 | 2009 | 1147 | 0.010 |
Why?
|
| Phylogeny | 1 | 2010 | 1190 | 0.010 |
Why?
|
| Escherichia coli Infections | 1 | 2004 | 35 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2010 | 2019 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 1847 | 0.010 |
Why?
|
| Nystatin | 1 | 2002 | 2 | 0.010 |
Why?
|
| Filipin | 1 | 2002 | 2 | 0.010 |
Why?
|
| Fas-Associated Death Domain Protein | 1 | 2002 | 8 | 0.010 |
Why?
|
| Cyclodextrins | 1 | 2002 | 7 | 0.010 |
Why?
|
| Ionophores | 1 | 2002 | 14 | 0.010 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2002 | 25 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 6834 | 0.010 |
Why?
|
| Caspase 8 | 1 | 2002 | 34 | 0.010 |
Why?
|
| Caspase 9 | 1 | 2002 | 49 | 0.010 |
Why?
|
| Caspase Inhibitors | 1 | 2002 | 33 | 0.010 |
Why?
|
| Membrane Microdomains | 1 | 2002 | 54 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2002 | 245 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2002 | 436 | 0.010 |
Why?
|
| Lymphocytes | 1 | 2002 | 471 | 0.010 |
Why?
|
| Mitochondria | 1 | 2002 | 553 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2002 | 790 | 0.010 |
Why?
|